Evidence map›Paper›PMID 30880959›Full record

ArticleInternational journal of nanomedicine2019

Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant

Shijing Liao, Yapeng Zhang, Xuanhe Pan, Feizhou Zhu, Congyuan Jiang, Qianqian Liu, Zhongyi Cheng, Gan Dai, Guojun Wu, Linqian Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 1 pooled it
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 1 synthesis or guideline pooled it, 462 citations in OpenAlex.

  1. Metal Nanoparticles in Infection and Immunity.Immunological investigations · 2020
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Green Synthesis of Ag/TiOACS omega · 2026
    Article
  10. Article
  11. Veterinary world · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shijing LiaoDepartment of Medical Microbiology, School of Basic Medical Sciences, Central South University, Changsha 410013, China, chenliyu@csu.edu.cn.
Yapeng ZhangDepartment of Medical Microbiology, School of Basic Medical Sciences, Central South University, Changsha 410013, China, chenliyu@csu.edu.cn.
Xuanhe PanDepartment of Medical Microbiology, School of Basic Medical Sciences, Central South University, Changsha 410013, China, chenliyu@csu.edu.cn.
Feizhou ZhuDepartment of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, Changsha 410013, China.
Congyuan JiangHunan Anson Biotechnology Co., Ltd., Changsha 410008, China.
Qianqian LiuDepartment of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, Changsha 410013, China.
Zhongyi ChengJingjie PTM BioLab Co., Ltd., Hangzhou Economic and Technological Development Area, Hangzhou 310018, China.
Gan DaiDepartment of Medical Microbiology, School of Basic Medical Sciences, Central South University, Changsha 410013, China, chenliyu@csu.edu.cn.
Guojun WuDepartment of Medical Microbiology, School of Basic Medical Sciences, Central South University, Changsha 410013, China, chenliyu@csu.edu.cn.
Linqian WangDepartment of Clinical Laboratory, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China, castlelins@163.com.
Liyu ChenDepartment of Medical Microbiology, School of Basic Medical Sciences, Central South University, Changsha 410013, China, chenliyu@csu.edu.cn.
Central South University · CNNew England Biolabs (China) · CNSansure Biotech (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe threat of drug-resistant

objectiveThis study aimed to investigate the antibacterial activity and mechanism of silver nanoparticles (AgNPs) against multidrug-resistant

methodsThe antimicrobial effect of AgNPs on clinical isolates of resistant

resultsAntimicrobial tests revealed that AgNPs had highly bactericidal effect on the drug-resistant or multidrug-resistant

conclusionThis study proved that AgNPs could play antimicrobial roles on the multidrug-resistant

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialMetal NanoparticlesMicrobial Sensitivity TestsPseudomonas aeruginosaPseudomonas InfectionsSilverAnti-Bacterial AgentsSilverAgNPsantibacterial activitymechanismmultidrug-resistant bacteriumPseudomonas aeruginosasilver nanoparticles

Identifiers

PMID30880959
PMCPMC6396885
OpenAlexW2915089534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.